CME Group (CME) Fundamental Analysis: Revenue, Earnings & Valuation

8.33 / 10

Outperform

Fundamentally, CME scores 8.3/10 and is rated Outperform. Strong points include rapid receivables collection, robust YoY profit and cash‑flow growth, and favorable revenue‑to‑market value. However, PB‑ROE and Asset‑MV are weak, tempering the otherwise solid profile.

Analysis Checks(6/10)

Revenue-MV

Value-1.44

Score3/3

Weight39.04%

1M Return13.06%

Days sales outstanding

Value35.87

Score2/3

Weight4.34%

1M Return1.06%

Profit-MV

Value0.89

Score0/3

Weight-19.45%

1M Return-7.03%

Accounts receivable turnover ratio

Value10.04

Score2/3

Weight2.01%

1M Return0.50%

PB-ROE

Value-0.57

Score0/3

Weight-8.46%

1M Return-2.71%

Total profit (YoY growth rate %)

Value17.38

Score3/3

Weight19.82%

1M Return4.88%

Net cash flow from operating activities (YoY growth rate %)

Value15.89

Score3/3

Weight20.03%

1M Return4.87%

Asset-MV

Value-0.55

Score1/3

Weight19.05%

1M Return4.22%

Net profit attributable to parent company shareholders (YoY growth rate %)

Value15.50

Score3/3

Weight20.53%

1M Return5.03%

Cash-MV

Value-0.34

Score1/3

Weight3.08%

1M Return0.84%

Is CME undervalued or overvalued?

CME scores 8.33/10 on fundamentals and holds a Discounted valuation at present. Backed by its 14.56% ROE, 62.45% net margin, 26.63 P/E ratio, 3.73 P/B ratio, and 15.38% earnings growth, these metrics solidify its Outperform investment rating.